Multimodal Imaging-Based Theragnostics
Abstract
Multimodal imaging-based theragnostics combines diagnostic imaging and therapeutic delivery into one platform, providing substantial progress in individualized treatment. By integrating several imaging modalities, including MRI, CT, PET, fluorescence, and ultrasound, it offers a holistic perspective of disorders at both molecular and tissue levels. Nanoparticles are essential in this method, allowing for focused administration of therapeutic drugs and permitting accurate imaging. This collaboration promotes diagnostic precision, improves treatment effectiveness, and facilitates real-time monitoring of therapy responses. Notwithstanding obstacles, ongoing research in nanoparticle design and multimodal imaging technologies presents significant potential for the future of healthcare.
Fields of Study & Subjects
Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Ultrasound and Hyperthermia Applications
Publication details
- Journal / source
- Biomedical Theragnostics Nanoplatforms
- Publisher
- CRC Press
- Pages
- 179–202
- Publication date
- 20 January 2026
- Language
- EN
- Document type
- Book chapter